Results 161 to 170 of about 862,104 (211)

Dopamine receptor antagonists/promazine

Reactions Weekly, 2008
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

A NEW DOPAMINE ANTAGONIST

InPharma, 1976
openaire   +1 more source

Lack of specific effects of selective D(1) and D(2) dopamine antagonists vs. risperidone on morphine-induced hyperactivity.

Pharmacology, Biochemistry and Behavior, 2000
M. Rodríguez-Arias, I. Broseta, M. Aguilar, J. Miñarro   +3 more
semanticscholar   +1 more source

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly  

Effects of Dopamine Agonist, Bromocriptine, and Some Dopamine Antagonists on Ocular Blood Flow

Journal of ocular pharmacology, 1992
G. Chiou, Yijun Chen
semanticscholar   +1 more source

Dopamine receptor antagonists/trimipramine

Reactions Weekly, 2009
openaire   +1 more source

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera, Hagop M Kantarjian, Victoria S Blinder   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi, Katherine A Hutcheson, Gary H Lyman   +2 more
exaly